tiprankstipranks
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
US Market
MAYNF
Mayne Pharma Group
RESEARCH TOOLSreports
Want to see MAYNF full AI Analyst Report?

Mayne Pharma Group (MAYNF) Income Statement

25 Followers

Mayne Pharma Group Income Statement

Last quarter (Q2 2026), Mayne Pharma Group's total revenue was AU$212.07M, an increase of 12.85% from the same quarter last year. In Q2, Mayne Pharma Group's net income was AU$-14.94M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78M
Gross Profit
AU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02M
Operating Expenses
AU$ 270.87MAU$ 357.59MAU$ 213.28MAU$ 145.62MAU$ 125.65M
Depreciation and Amortization
AU$ 64.11MAU$ 68.46MAU$ 65.44MAU$ 55.18MAU$ 68.19M
EBITDA
AU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40M
Operating Income
AU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88MAU$ 1.36M
Other Income/Expenses
AU$ -59.70MAU$ -51.02MAU$ -83.25MAU$ -23.71MAU$ -265.25M
Pretax Income
AU$ -83.30MAU$ -190.09MAU$ -269.70MAU$ -145.59MAU$ -263.89M
Net Income
AU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29MAU$ -208.42M
Per Share Metrics
Basic EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Diluted EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Weighted Average Shares Outstanding
 82.31M 79.62M 81.25M 81.25M 81.25M
Weighted Average Shares Outstanding (Diluted)
 79.14M 79.62M 81.25M 81.25M 81.25M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History